CU6 clarity pharmaceuticals ltd

Ann: First patient imaged in Phase III AMPLIFY trial, page-14

  1. 2,282 Posts.
    lightbulb Created with Sketch. 424
    I'm not sure if the ease of distribution is enough of a differentiator imo. TLX gozellix kit appears to have a good shelf life which nullifies this. Efficacy in the guise of sensitivity for a diagnostic will be the main attractor for clinicians wanting to use cu6, if cu64 ends up with a much higher sensitivity.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.29
Change
0.060(2.69%)
Mkt cap ! $739.1M
Open High Low Value Volume
$2.30 $2.37 $2.21 $4.838M 2.103M

Buyers (Bids)

No. Vol. Price($)
12 11509 $2.28
 

Sellers (Offers)

Price($) Vol. No.
$2.29 2596 13
View Market Depth
Last trade - 13.55pm 17/06/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.